Table 5. Patients with malignant pathology following RRBSO.

Patient	Genetic test result	Age at testing	Cancer history	Surgery performed	Final pathology
Patient 84	Negative	41	Cervical cancer	TAH BSO	Ovarian malignancy
Patient 112	Negative	42	HR+ breast cancer	BSO	Ovarian/tubal malignancy
Patient 218	Negative	49	HR+ breast cancer	TAH BSO	Uterine malignancy
Patient 343	Favor polymorphism	67	HR+ breast cancer	TAH BSO	Uterine malignancy

RRBSO, risk-reducing bilateral salpingo-oophorectomy; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; HR, hormone receptor.